These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3793498)

  • 21. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications.
    Bodei L; Kassis AI; Adelstein SJ; Mariani G
    Cancer Biother Radiopharm; 2003 Dec; 18(6):861-77. PubMed ID: 14969599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
    Kawashima H
    ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential].
    Mach JP; Pèlegrin A; Folli S; Buchegger F
    Bull Acad Natl Med; 1992 Jun; 176(6):879-89. PubMed ID: 1464034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical assessment of radiation doses using labelled antibodies for therapy.
    Myers MJ; Epenetos AA; Hooker G
    Int J Rad Appl Instrum B; 1986; 13(4):437-46. PubMed ID: 3793499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies.
    Goldenberg DM; Blumenthal RD; Sharkey RM
    Semin Cancer Biol; 1990 Jun; 1(3):217-25. PubMed ID: 2103497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G
    Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radionuclide therapy in oncology.
    Clarke SE
    Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
    [No Abstract]   [Full Text] [Related]  

  • 29. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
    Humm JL
    J Nucl Med; 1986 Sep; 27(9):1490-7. PubMed ID: 3528417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies.
    Wessels BW; Rogus RD
    Med Phys; 1984; 11(5):638-45. PubMed ID: 6503879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.
    Siegel JA; Pawlyk DA; Lee RE; Sasso NL; Horowitz JA; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):1039s-1042s. PubMed ID: 2297717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
    Press OW; Shan D; Howell-Clark J; Eary J; Appelbaum FR; Matthews D; King DJ; Haines AM; Hamann P; Hinman L; Shochat D; Bernstein ID
    Cancer Res; 1996 May; 56(9):2123-9. PubMed ID: 8616860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.
    Badger CC; Krohn KA; Shulman H; Flournoy N; Bernstein ID
    Cancer Res; 1986 Dec; 46(12 Pt 1):6223-8. PubMed ID: 3779642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Appelbaum FR
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1013-25. PubMed ID: 1938754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
    Yao Z; Garmestani K; Wong KJ; Park LS; Dadachova E; Yordanov A; Waldmann TA; Eckelman WC; Paik CH; Carrasquillo JA
    J Nucl Med; 2001 Oct; 42(10):1538-44. PubMed ID: 11585870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cancer radiopharmaceuticals.
    Hoefnagel CA
    Anticancer Drugs; 1991 Apr; 2(2):107-32. PubMed ID: 1958857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
    J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in cancer therapy with radiolabeled monoclonal antibodies.
    Goldenberg DM; Sharkey RM
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use].
    Lundqvist H; Carlsson J; Gedda L; Tolmachev V; Garske U; Kairemo K
    Lakartidningen; 2004 Mar; 101(11):1000-2, 1005-6. PubMed ID: 15055121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.